Nephrology

Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder with an incidence of 1 in 3,000–5,000.

Chronic kidney disease (CKD) is a progressive condition that can lead to kidney failure and the requirement for renal dialysis or transplantation. Early-stage CKD is often missed because the disorder is initially asymptomatic; hence, many patients with CKD already have symptomatic advanced disease (Stages G4–G5) at the time of diagnosis. This is an important issue because the drugs available for the treatment of CKD are most effective when given during the early stages of the disease (Stages G1–G3).

Previously, membranous nephropathies were divided into primary and secondary categories when the exact mechanism or pathogenetic factor were unknown. Approximately 70% accounted for primary membranous nephropathies. The remaining 30% were called secondary because they developed due to well-known diseases such as autoimmune diseases, tumours, infections, or drug assumptions.

This article details the diagnosis and treatment of IgA nephropathy and focal segmental glomerulosclerosis, as discussed in a symposium delivered as part of the European Renal Association (ERA) 59th Congress in Paris, 19th−22nd May 2022.

In this symposium, the pathological background of the association between the uremic milieu and inflammation and pathways for poor outcomes in patients on haemodialysis (HD)

Talking to John Sperati, Director of Nephrology Fellowship Training Program and Associate Professor of Medicine at Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Public health in sub-Saharan African countries is experiencing a double burden of diseases. Unfortunately, the health systems in sub-Saharan Africa are vulnerable, under-resourced, and unable to address these public health issues.

The primary reason is that it’s the most impactful disease that affects nephrology. When I was in training, there was only one medicine…